Impact of Smart Watch Mobile Application on Risk Treatment of CardioVascular Disease

Asan Medical Center0 个研究点目标入组 450 人开始时间: 待定最近更新: 2023年5月30日

试验速览

暂无简介。

•health insurance subscribers who are aged 20-54 years
•24-hour ambulatory systolic BP 130-159 mmHg or serum LDL =130 mg/dl
•Android smartphone users who can use ICT-based helathcare application
•no use of anti-hypertensive or lipid-lowering drugs for =3 months prior to screening
•subjects who are considered appropriate to be managed with lifestyle modification for 12 weeks
•Subject who understands the purpose of the study and signs with informed consent form

•24-hour ambulatory systolic or diastolic BP >160 mmHg or > 110 mmHg
•underlying cardiovascular disease (ischemic heart disease, heart failure, aortic disease, valvular heart disease, arrhythmia, cardiomyopathy, etc.)
•underlying cerebrovascular disease (stroke, cerebral infarction or hemorrhage, cerebral aneurysm, etc.)
•chronic renal disease
•peripheral vascular disease
•secondary hypertension
•atrial fibrillation or flutter
•severe bradyarrhythmia
•difficulty in BP measurement by smart watch
•difference in systolic BP measurements from both arms > 10mmHg
•life expectancy < 2 years
•medical conditions that would limit adherence to participation (as confirmed by physicians)

发起方